1. Home
  2. MREO vs AENT Comparison

MREO vs AENT Comparison

Compare MREO & AENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • AENT
  • Stock Information
  • Founded
  • MREO 2015
  • AENT 1990
  • Country
  • MREO United Kingdom
  • AENT United States
  • Employees
  • MREO N/A
  • AENT N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • AENT Durable Goods
  • Sector
  • MREO Health Care
  • AENT Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • AENT Nasdaq
  • Market Cap
  • MREO 281.6M
  • AENT 254.3M
  • IPO Year
  • MREO N/A
  • AENT N/A
  • Fundamental
  • Price
  • MREO $1.79
  • AENT $6.00
  • Analyst Decision
  • MREO Strong Buy
  • AENT Strong Buy
  • Analyst Count
  • MREO 5
  • AENT 1
  • Target Price
  • MREO $7.40
  • AENT $10.00
  • AVG Volume (30 Days)
  • MREO 1.2M
  • AENT 42.6K
  • Earning Date
  • MREO 08-12-2025
  • AENT 09-10-2025
  • Dividend Yield
  • MREO N/A
  • AENT N/A
  • EPS Growth
  • MREO N/A
  • AENT N/A
  • EPS
  • MREO N/A
  • AENT 0.23
  • Revenue
  • MREO $500,000.00
  • AENT $1,072,641,000.00
  • Revenue This Year
  • MREO N/A
  • AENT N/A
  • Revenue Next Year
  • MREO $55.50
  • AENT $2.01
  • P/E Ratio
  • MREO N/A
  • AENT $26.90
  • Revenue Growth
  • MREO N/A
  • AENT N/A
  • 52 Week Low
  • MREO $1.47
  • AENT $1.62
  • 52 Week High
  • MREO $4.72
  • AENT $11.57
  • Technical
  • Relative Strength Index (RSI)
  • MREO 52.86
  • AENT 59.53
  • Support Level
  • MREO $1.68
  • AENT $5.61
  • Resistance Level
  • MREO $1.83
  • AENT $6.34
  • Average True Range (ATR)
  • MREO 0.08
  • AENT 0.49
  • MACD
  • MREO 0.03
  • AENT 0.07
  • Stochastic Oscillator
  • MREO 82.61
  • AENT 74.07

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.

Share on Social Networks: